Aaby, P, Knudsen, K, Jensen, TG et al. , Measles incidence, vaccine efficacy and mortality in two urban African areas with high vaccination coverage. J Infect Dis 1990; 162: 1043–8.
Aaby, P, Clements, J. Measles immunization research. A review. Bull WHO 1989; 67: 443–8.
Loening, WEK, Coovadia, HM. Age–specific occurrence rates of measles in urban, peri–urban, and rural environments: implications for time of vaccination. Lancet 1983; ii: 324–6.
Dabis, F, Sow, A, Waldman, RJ et al. , The epidemiology of measles in a partially vaccinated population in an African city: implications for immunization programmes. Am J Epidemiol 1988; 127: 171–8.
Whittle, H, Hanlon, P, O'Neill, K et al. , Trial of high–dose Edmonston–Zagreb measles vaccine in The Gambia: antibody response and side-effects. Lancet 1988; ii: 811–14.
Tidjani, O, Grunitsky, B, Guerin, N et al. , Serological effects of Edmonston–Zagreb, Schwarz, and AIK–C measles vaccine strains given at ages 4–5 or 8–10 months. Lancet 1989; ii: 1357–60.
Markowitz, LE, Sepulveda, J, Diaz-Ortega, JL et al. , Immunization of six–month–old infants with different doses of Edmonston–Zagreb and Schwarz measles vaccines. N Engl J Med 1990; 322: 580–7.
Aaby, P, Jensen, TG, Hansen, HL et al. , Trial of high–dose Edmonston–Zagreb measles vaccine in Guinea–Bissau: protective efficacy. Lancet 1988; ii: 809–11.
9.Expanded Programme on Immunization: Global Advisory Group. Weekly Epidem Rec 1990; 65: 5–11.
Whittle, HC, Campbell, H, Rahman, S, Armstrong, JRM. Antibody persistence in Gambian children after high–dose Edmonston–Zagreb measles vaccine. Lancet 1990; 336: 1046–8.
Aaby, P, Knudsen, K, Whittle, H et al. , Long–term survival after Edmonston–Zagreb measles vaccination: increased female mortality. J Pediatr 1993; 122: 904–8.
Aaby, P, Samb, B, Simondon, Knudsen K et al. , Divergent mortality for male and female recipients of low-titre and high–titre measles vaccines in rural Senegal. Am J Epidemiol 1993; 138: 746–55.
Halsey, N. Increased mortality following high titre measles vaccines: too much of a good thing. J Pediatr Infect Dis 1993: 12: 462–5.
14.Expanded Programme on Immunization. Consultation on studies involving high titre measles vaccines. Weekly Epidemiol Rec 1992; 67: 357–61.
Whittle, HC, Mann, G, Eccles, M et al. , Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4–5 months. Lancet 1988; 1: 963–6.
Hall, A, Aaby, P. Tropical trials and tribulations. Int J Epidemiol 1990; 19: 777–81.
Lisse, IM, Whittle, H, Aaby, P, Normark, M, Gyhrs, A, Ryder, LP. Labelling of T–cell subsets under field conditions in tropical countries. Adaptation of the immuno–alkaline phosphatase staining method for blood–smears. J Immunol Methods 1990; 129: 49–53.
Cox, DR, Oakes, D. Analysis of survival data. London: Chapman and Hall, 1984.
Aaby, P, Andersen, M, Sodemann, , Jakobsen, M, Gomes, J, Fernandes, M. Reduced childhood mortality following standard measles vaccination at 4–8 months compared to 9–11 months of age. BMJ 1993; 307: 1308–11.